You can buy or sell KZR and other stocks, options, ETFs, and crypto commission-free!
Kezar Life Sciences, Inc. Common Stock, also called Kezar Life Sciences, is a clinical-stage biotechnology company, which discovers and develops novel small molecule therapeutics to treat autoimmunity and cancer. Read More The firm specializes in the areas of protein degradation and protein secretion to discover & develop novel therapies for the treatment of serious and unmet medical needs. Its product include KZR-616, an immunoproteasome inhibitor, has completed testing in healthy volunteers. The company was founded by John Fowler, Christopher J. Kirk and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
Expected Nov 7, After Hours